Houston, TX -- (SBWire) -- 04/03/2018 --Increase in the number of genome research activities for disease research, development trend of umbilical cord blood stem cells and bio-banking in newborns, government and private fund support for bio-banking research on regenerative medicine, and bio-banking market.
Global biobanking markets are categorized by product and service, sample type, storage type, application and region. By product and service, the biobank market is divided into equipment, supplies, services and software. The equipment division is expected to lead the global bio-banking market in 2017. The increase in the number of bio-banks and the number of bio-samples to be stored are increasing demand for bio-banking equipments.
By product and service, the biobank market is divided into equipment, supplies, services and software. The equipment division is expected to dominate the global bio-banking market in 2017. Demand for bio-banking equipment can increase as the number of bio-banks increases and biomarkers increase.
Global Biobanking market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including: Beckman Coulter, Thermo Fisher, Panasonic, Sigma-Aldrich, SOL Group, Promega, BD, Brooks Life Science, QIAGEN, Tecan Group, Lifeline Scientific, So-Low, LVL Technologies, DNA Genotek, Micronic, Askion, Biolife Solutions, Cryo Bio System, BioRep
For Sample Copy of this report: https://www.researchnreports.com/request_sample.php?id=78005
The biobanking market is divided into blood products, human tissues, nucleic acids, human waste, cell lines and body fluids by sample type. In 2017, the blood product segment is expected to anticipate, against the largest share of the biobanking market by sample type. Growth in this area is accelerating as the incidence of blood diseases increases and the demand for diverse blood products worldwide increases.
Depending on the region, the bio-banking market is divided into North America, Europe, Asia-Pacific and other regions (RoW). North America is expected to dominate the bio-banking market in 2017. This is due to factors such as increased research activity on regenerative medicine, cell and gene therapy. Increased interest in personalized drug and biomarker discovery. Biotechnology and pharmaceutical companies are increasing their investments in genomics and proteomics research in this area compared to other regions.
Avail Discount: https://www.researchnreports.com/ask_for_discount.php?id=78005
By sample type, the biobanking market is divided into blood products, human tissues, cell lines, nucleic acids, human waste and body fluids. Because blood and blood products are the most commonly collected samples and are used as a source of DNA and RNA, this classification type holds the largest share in the market.
Based on the application, the Biobanking market is divided into regenerative medicine, life science research and clinical research. Regeneration medicine is expected to account for the largest portion of the market in 2017. Increased research on regenerative medicine and increased demand for well-characterized and quality biosamples for research are key reasons for growth in this market segment.
Know About the Incredible Possibilities of Global Biobanking Market by 2022 According to New Research
Key Players profiled in this report are: Beckman Coulter, Thermo Fisher, Panasonic, Sigma-Aldrich, SOL Group, Promega, BD, Brooks Life Science, QIAGEN, Tecan Group, Lifeline Scientific, So-Low, LVL Technologies, DNA Genotek, Micronic, Askion, Biolife Solutions, Cryo Bio System, BioRep.